175 related articles for article (PubMed ID: 19116451)
1. CD36 signaling inhibits the translation of heat shock protein 70 induced by oxidized low density lipoprotein through activation of peroxisome proliferators-activated receptor gamma.
Lee KJ; Ha ES; Kim MK; Lee SH; Suh JS; Lee SH; Park KH; Park JH; Kim DJ; Kang D; Kim BC; Jeoung D; Kim YK; Kim HD; Hahn JH
Exp Mol Med; 2008 Dec; 40(6):658-68. PubMed ID: 19116451
[TBL] [Abstract][Full Text] [Related]
2. Antagonistic effects of oxidized low density lipoprotein and alpha-tocopherol on CD36 scavenger receptor expression in monocytes: involvement of protein kinase B and peroxisome proliferator-activated receptor-gamma.
Munteanu A; Taddei M; Tamburini I; Bergamini E; Azzi A; Zingg JM
J Biol Chem; 2006 Mar; 281(10):6489-97. PubMed ID: 16407258
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM.
Yu M; Jiang M; Chen Y; Zhang S; Zhang W; Yang X; Li X; Li Y; Duan S; Han J; Duan Y
J Biol Chem; 2016 Aug; 291(33):16977-89. PubMed ID: 27358406
[TBL] [Abstract][Full Text] [Related]
4. Ox-LDL suppresses PMA-induced MMP-9 expression and activity through CD36-mediated activation of PPAR-g.
Lee KJ; Kim HA; Kim PH; Lee HS; Ma KR; Park JH; Kim DJ; Hahn JH
Exp Mol Med; 2004 Dec; 36(6):534-44. PubMed ID: 15665586
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin inhibited oxLDL-induced proatherogenic effects through calpain-1-PPARγ-CD36 pathway.
Yang X; Yin M; Yu L; Lu M; Wang H; Tang F; Zhang Y
Can J Physiol Pharmacol; 2016 Dec; 94(12):1336-1343. PubMed ID: 27733051
[TBL] [Abstract][Full Text] [Related]
6. IL-13 induces expression of CD36 in human monocytes through PPARgamma activation.
Berry A; Balard P; Coste A; Olagnier D; Lagane C; Authier H; Benoit-Vical F; Lepert JC; Séguéla JP; Magnaval JF; Chambon P; Metzger D; Desvergne B; Wahli W; Auwerx J; Pipy B
Eur J Immunol; 2007 Jun; 37(6):1642-52. PubMed ID: 17458857
[TBL] [Abstract][Full Text] [Related]
7. AICAR inhibits PPARγ during monocyte differentiation to attenuate inflammatory responses to atherogenic lipids.
Namgaladze D; Kemmerer M; von Knethen A; Brüne B
Cardiovasc Res; 2013 Jun; 98(3):479-87. PubMed ID: 23531513
[TBL] [Abstract][Full Text] [Related]
8. Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonists.
Davies SS; Pontsler AV; Marathe GK; Harrison KA; Murphy RC; Hinshaw JC; Prestwich GD; Hilaire AS; Prescott SM; Zimmerman GA; McIntyre TM
J Biol Chem; 2001 May; 276(19):16015-23. PubMed ID: 11279149
[TBL] [Abstract][Full Text] [Related]
9. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma.
Feng J; Han J; Pearce SF; Silverstein RL; Gotto AM; Hajjar DP; Nicholson AC
J Lipid Res; 2000 May; 41(5):688-96. PubMed ID: 10787429
[TBL] [Abstract][Full Text] [Related]
10. Tanshinone IIA attenuates atherosclerosis in ApoE(-/-) mice through down-regulation of scavenger receptor expression.
Tang FT; Cao Y; Wang TQ; Wang LJ; Guo J; Zhou XS; Xu SW; Liu WH; Liu PQ; Huang HQ
Eur J Pharmacol; 2011 Jan; 650(1):275-84. PubMed ID: 20854809
[TBL] [Abstract][Full Text] [Related]
11. Activation of Peroxisome Proliferator-activated Receptor γ (PPARγ) and CD36 Protein Expression: THE DUAL PATHOPHYSIOLOGICAL ROLES OF PROGESTERONE.
Yang X; Zhang W; Chen Y; Li Y; Sun L; Liu Y; Liu M; Yu M; Li X; Han J; Duan Y
J Biol Chem; 2016 Jul; 291(29):15108-18. PubMed ID: 27226602
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice.
Collins AR; Meehan WP; Kintscher U; Jackson S; Wakino S; Noh G; Palinski W; Hsueh WA; Law RE
Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):365-71. PubMed ID: 11231915
[TBL] [Abstract][Full Text] [Related]
13. Activation of PPARγ does not contribute to macrophage ABCA1 expression and ABCA1-mediated cholesterol efflux to apoAI.
Jiang M; Li X
Biochem Biophys Res Commun; 2017 Jan; 482(4):849-856. PubMed ID: 27890613
[TBL] [Abstract][Full Text] [Related]
14. Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor gamma ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells--potential for dietary modulation of peroxisome proliferator-activated receptor gamma in intestinal inflammation.
Marion-Letellier R; Butler M; Déchelotte P; Playford RJ; Ghosh S
Am J Clin Nutr; 2008 Apr; 87(4):939-48. PubMed ID: 18400717
[TBL] [Abstract][Full Text] [Related]
15. Role of PPAR-gamma in the modulation of CD36 and FcgammaRII induced by LDL with low and high degrees of oxidation during the differentiation of the monocytic THP-1 cell line.
Rios FJ; Jancar S; Melo IB; Ketelhuth DF; Gidlund M
Cell Physiol Biochem; 2008; 22(5-6):549-56. PubMed ID: 19088437
[TBL] [Abstract][Full Text] [Related]
16. Enzymatically modified low-density lipoprotein upregulates CD36 in low-differentiated monocytic cells in a peroxisome proliferator-activated receptor-gamma-dependent way.
Jostarndt K; Rubic T; Kuhn H; Anthosen MW; Andera L; Gellert N; Trottman M; Weber C; Johansen B; Hrboticky N; Neuzil J
Biochem Pharmacol; 2004 Mar; 67(5):841-54. PubMed ID: 15104237
[TBL] [Abstract][Full Text] [Related]
17. Oxygenized low density lipoprotein down-regulates the TRPV4 protein expression of macrophage through activation of peroxisome proliferator-activated receptor γ.
Xue C; Gong J; Guo Y; Yin J; He X; Huang H; Zhou X; Zhao J
Minerva Med; 2017 Feb; 108(1):1-12. PubMed ID: 27706112
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone inhibits oxidized low-density lipoprotein-induced macrophage proliferation: impact of the suppression of nuclear translocation of ERK1/2.
Yano M; Matsumura T; Senokuchi T; Ishii N; Motoshima H; Taguchi T; Matsuo T; Sonoda K; Kukidome D; Sakai M; Kawada T; Nishikawa T; Araki E
Atherosclerosis; 2007 Mar; 191(1):22-32. PubMed ID: 16725145
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor γ agonist troglitazone inhibits high mobility group box 1 expression in endothelial cells via suppressing transcriptional activity of nuclear factor κB and activator protein 1.
Gao M; Hu Z; Zheng Y; Zeng Y; Shen X; Zhong D; He F
Shock; 2011 Sep; 36(3):228-34. PubMed ID: 21617575
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Glutathione Production Induces Macrophage CD36 Expression and Enhances Cellular-oxidized Low Density Lipoprotein (oxLDL) Uptake.
Yang X; Yao H; Chen Y; Sun L; Li Y; Ma X; Duan S; Li X; Xiang R; Han J; Duan Y
J Biol Chem; 2015 Sep; 290(36):21788-99. PubMed ID: 26187465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
